Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost semaglutide side effects are gastrointestinal, arrive in the first few days after a new dose, and settle on their own within one to two weeks. That pattern holds for the majority of people, though some find symptoms linger longer at certain dose steps. These are prescription-only medicines; a prescriber assesses your full picture before treatment begins, and the full side-effect profile of semaglutide is worth understanding before you start.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Imagine you've just taken your first Wegovy injection (or moved up from 1mg to 1.7mg) and by day three you're finding meals unappealing and your stomach is making its feelings known. That is the most common scenario, and it is also, in most cases, temporary. Semaglutide slows gastric emptying: food moves through your stomach more gradually, which reduces appetite but can also cause nausea, burping, reflux and loose stools. The body isn't used to that change yet.
For most people, these symptoms are mildest at the starting dose (0.25mg) and become more noticeable with each upward step. The intensity tends to peak in the first two to five days after the injection, then gradually fades over the following week or so. By the time the next weekly dose is due, many people feel considerably more settled. The Wegovy side-effect page maps out the full list of what the clinical trials reported, if you want more detail.
Practical things that help during this window: smaller portions, eating slowly, keeping meals low in fat and sugar, and drinking water steadily through the day rather than in large amounts at once. These are consistent with NHS guidance on semaglutide, which also recommends avoiding rich or spicy food while your body adjusts.
Some people find that nausea or fatigue doesn't lift cleanly after the first week. At a new dose, two weeks is a reasonable window to allow before concluding that symptoms are lasting longer than typical. A few things tend to prolong them: eating large meals, eating quickly, lying down shortly after food, and insufficient hydration when diarrhoea or vomiting are present.
If symptoms are still disruptive at the two-week mark, the answer is almost never to push through alone. Dose timing matters too — if you've just moved to a higher pen because your repeat arrived on payday rather than at the four-week mark, that overlap can compound things. Speak to the prescriber team about whether the pace of titration is right for you. Slowing the escalation schedule is a legitimate clinical decision, not a setback.
If you're wondering how long semaglutide side effects typically last at each dose step, including the longer titration path now possible with the 7.2mg pen, our detailed timeline covers what to expect throughout the process.
There is a category of symptoms where waiting is the wrong response. Severe, persistent stomach pain (particularly if it radiates into the back, with or without vomiting) requires same-day medical contact. This is the symptom pattern associated with acute pancreatitis, which the MHRA flagged in a Drug Safety Update in January 2026 as an infrequent but serious risk with GLP-1 medicines. It is rare; it still matters.
Other symptoms that warrant prompt attention rather than watchful waiting: signs of a serious allergic reaction (facial swelling, difficulty breathing, rapid heartbeat), severe vomiting or diarrhoea that prevents you keeping fluids down (dehydration can affect kidney function), and yellowing of the skin or eyes, which may indicate gallbladder or liver involvement. If you've had pancreatitis before, read about whether Wegovy is suitable after a pancreatitis history before starting.
You can report any suspected side effect (including ones that surprised you or that you're unsure about) through the MHRA Yellow Card scheme. That reporting genuinely helps regulators track patterns across thousands of patients.
The duration of semaglutide side effects is not entirely fixed, and if you want a clearer sense of what the research says, our guide on how long semaglutide side effects last breaks this down by symptom and dose stage. The titration schedule (how quickly doses increase) is one of the main levers. Clinical guidance allows for pausing at a dose level if side effects are significant, rather than escalating on a rigid calendar. Most people find that doing this once or twice during the early months means they reach a therapeutic dose with far less disruption.
At nume, our prescribers review every repeat order; a dose increase isn't automatic. If your notes flag persistent nausea or weight-loss progress at a lower dose, the prescriber looks at the whole picture before signing off the next step. That is the kind of clinical oversight that makes a real difference to tolerability over time. If you'd like to understand more about the treatment itself before taking that step, the Wegovy treatment overview is a good place to start, and our free consultation is where you can raise all of this directly with the team.
Side effects are a genuine part of treatment for many people. They are also, for the large majority, a temporary phase rather than a permanent feature, and one that can be managed with the right support.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.